People

Ward Capoen
Ward Capoen serves as Board member at Sibylla Biotech. A V-Bio investor who joined in2016 after molecular-biology research and biotechnology investment analysis at Candriam. Holds Ghent biotechnology doctorate and Vlerick MBA.
Roles
Sibylla Biotech
CurrentBoard member
V-Bio Ventures
CurrentPartner
Augustine Therapeutics
CurrentInterim Management (2019 company launch; historical)